QuiVad

Home / Netherlands / Pharming Group N.V.

Pharming Group N.V.

Short position disclosed on October 22, 2026.

Follow

Evolution of the disclosed total

0%2.5%5%7.5%10%
Jan 2026Apr 2026Jul 2026Oct 2026
Sum of open short positions, asĀ % of capital. Hover or tap the curve to see which funds make it up.
Over the whole history, the total peaked at 8.84% on July 30, 2026. The shaded band matches the twelve months of the first chart.

January 23, 2014 today

Open positions

The funds disclosing a short position that is still open.
FundTwelve months% of capitalOver the yearSince
Two Sigma Investments, LP1.49%newOctober 22, 2026
Citadel Advisors LLC1.34%+0.11 ptOctober 22, 2026
D. E. Shaw & Co., L.P.1.03%newOctober 22, 2026
Citadel Securities (Europe) Limited0.80%newOctober 22, 2026
Capstone Volatility Master (Cayman) Limited0.72%-0.23 ptSeptember 11, 2026
Walleye Capital LLC0.69%newOctober 22, 2026
Whitebox Advisors LLC0.58%-0.02 ptJune 3, 2026
Spark Investment Management LLC0.52%newJune 19, 2026
Jupiter Asset Management Ltd.0.51%newSeptember 11, 2026
AQR Capital Management, LLC0.50%newOctober 8, 2026

In the United States PHGUF (OTC): 10,796,948 shares sold short on September 30, 2026. FINRA names no fund.

On the other side: the funds that hold Pharming Group N.V. Titelia

Follow by RSS

Get the moves on Pharming Group N.V. by mail, at most once a day.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

1,161 disclosures on record for this share.
DateFund% of capitalEnd of publication
February 29, 2024Citadel Advisors LLC1.13%
February 27, 2024Citadel Advisors LLC1.00%
February 21, 2024Citadel Advisors LLC0.91%
February 16, 2024Millennium International Management LP1.40%
February 16, 2024Citadel Advisors LLC0.80%
February 15, 2024Citadel Advisors LLC0.73%
February 14, 2024Millennium International Management LP1.30%
February 14, 2024Citadel Advisors LLC0.68%
February 13, 2024Millennium International Management LP1.19%
February 13, 2024Citadel Advisors LLC0.50%
February 12, 2024Millennium International Management LP0.90%
January 22, 2024Millennium International Management LP0.83%
January 18, 2024Millennium International Management LP0.72%
January 15, 2024Millennium International Management LP0.51%
December 29, 2023Arrowstreet Capital, Limited Partnership0.46%
December 28, 2023Marshall Wace LLP0.49%
December 19, 2023Marshall Wace LLP0.59%
December 14, 2023Marshall Wace LLP0.66%
November 21, 2023Marshall Wace LLP0.79%
November 21, 2023Arrowstreet Capital, Limited Partnership0.51%
November 15, 2023Marshall Wace LLP0.89%
November 7, 2023Marshall Wace LLP0.99%
November 2, 2023Marshall Wace LLP1.09%
October 27, 2023Marshall Wace LLP1.16%
October 16, 2023Marshall Wace LLP1.20%
October 5, 2023Marshall Wace LLP1.12%
October 3, 2023Marshall Wace LLP1.04%
September 26, 2023Marshall Wace LLP0.93%
September 21, 2023Marshall Wace LLP0.82%
September 13, 2023Marshall Wace LLP0.70%
August 30, 2023Marshall Wace LLP0.60%
August 22, 2023Marshall Wace LLP0.50%
August 11, 2023Citadel Advisors LLC0.47%
August 9, 2023Citadel Advisors LLC0.55%
August 8, 2023Citadel Advisors LLC0.65%
August 2, 2023Citadel Advisors LLC0.72%
August 1, 2023Citadel Advisors LLC0.62%
July 31, 2023Citadel Advisors LLC0.56%
July 27, 2023Citadel Advisors LLC0.69%
July 26, 2023Citadel Advisors LLC0.70%
July 26, 2023WorldQuant, LLC0.49%
July 21, 2023Citadel Advisors LLC0.65%
July 20, 2023WorldQuant, LLC0.55%
July 19, 2023Citadel Advisors LLC0.72%
July 11, 2023Citadel Advisors LLC0.67%
July 3, 2023WorldQuant, LLC0.69%
June 29, 2023WorldQuant, LLC0.73%
June 27, 2023WorldQuant, LLC0.63%
June 23, 2023WorldQuant, LLC0.50%
June 20, 2023Citadel Advisors LLC0.77%

Download 1,161 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in the Netherlands

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Pharming Group N.V., source AFM, data as at October 22, 2026, https://www.quivad.com/action/pharming-group-n-v?page=12